Colorectal cancer, which affects the colon and rectum, is one of the most common cancers worldwide and a major cause of ...

Pancreatic cancer is one of the deadliest forms of cancer with a poor prognosis rate. But a new study suggests that a vaccine ...

As a 12-year pancreatic cancer survivor, I share my journey through diagnosis, treatment and survival, hoping my story ...

Smoking has been linked to pancreatic cancer, but the reasons were unclear. A new mouse study shows that chemicals in ...

Tempus AI's PurIST test secures clinical validation, helping personalize treatment choices for advanced pancreatic cancer patients.

A combination of two chemotherapy drugs show promising results in fighting pancreatic cancer, according to a study presented at the American Society of Clinical Oncology’s annual meeting Friday. The ...

A recent study reveals that smoking not only elevates the risk of pancreatic cancer but also actively promotes tumor growth ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

Atebimetinib combined with modified chemotherapy achieved a 94% six-month overall survival rate in first-line pancreatic cancer patients, surpassing the typical 67% with standard treatment. The ...

Pancreatic cancer is a highly aggressive disease -- only 13% of patients typically survive five years after diagnosis. Early detection is so difficult. Here's one major symptom to watch for. It’s a ...

A phase 3 trial found that adding chemoradiotherapy (CRT) after induction chemotherapy in patients with unresectable pancreatic cancer did not extend overall survival compared to chemotherapy alone ...

The difference in survival rates between different types of cancer is bigger than ever while overall improvements have slowed, a study reveals. The proportion of UK patients surviving ten years or ...